Evidence map›Paper›PMID 41659336›Full record

ReviewFrontiers in endocrinology2025

Potential role of glucagon like peptide 1 in taste receptors.

Jose Luis Eduardo Doval-Caballero, Aldo Ferreira-Hermosillo, Genesis Dinora Eugenio-Ponce, Manuel Ramon García-Sáenz, Raúl Ibarra-Salce, Andrea Patricia Tenorio-Rojo, Eduardo Salif Luna-Avila, Paulo César Gete-Palacios, Fernando Pérez-Hernández, Eduardo Rojas-Milán and 2 more

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Expression ofbioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jose Luis Eduardo Doval-CaballeroObesity Clinic, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico.
Aldo Ferreira-HermosilloUnidad de Investigación Médica en Enfermedades Endocrinas, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Genesis Dinora Eugenio-PonceServicio de Endocrinología, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Manuel Ramon García-SáenzServicio de Endocrinología, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Raúl Ibarra-SalceUniversidad Autonoma de Coahuila, Saltillo, Mexico.
Andrea Patricia Tenorio-RojoUniversidad Autonoma de Coahuila, Saltillo, Mexico.
Eduardo Salif Luna-AvilaUnidad de Investigación Médica en Enfermedades Endocrinas, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Paulo César Gete-PalaciosUnidad de Investigación Médica en Enfermedades Endocrinas, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Fernando Pérez-HernándezObesity Clinic, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico.
Eduardo Rojas-MilánObesity Clinic, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico.
Luis Angel López-CruzUnidad de Investigación Médica en Enfermedades Endocrinas, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
César Alejandro Méndez-HernándezObesity Clinic, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The perception of taste is a complex physiological process that extends far beyond the simple detection of flavor molecules, serving as a critical interface between nutrient sensing, metabolic regulation, and feeding behavior. Emerging evidence reveals that this process is profoundly modulated by endocrine and neuromodulatory systems, creating a sophisticated gut-brain-taste axis that integrates peripheral gustatory signals with central homeostatic and hedonic mechanisms. Hormones such as glucagon-like peptide-1, leptin, ghrelin, and CCK not only regulate appetite and energy balance but also directly influence taste receptor expression and function in the tongue and gastrointestinal tract. Concurrently, neuromodulators like dopamine, serotonin, and norepinephrine fine-tune taste sensitivity at both peripheral (taste buds) and central (reward circuitry) levels, linking chemosensation to motivational states. These interactions are further complicated by metabolic conditions such as obesity and diabetes, where hormonal resistance (e.g., leptin, insulin) and neurotransmitter dysregulation contribute to altered taste preferences and compulsive eating behaviors.

Indexed as

Glucagon-Like Peptide 1Receptors, G-Protein-CoupledTasteTaste BudsTaste PerceptionAnimalsHumansGlucagon-Like Peptide 1Receptors, G-Protein-Coupledfood preferencesgastrointestinal hormonesglucagon-like peptide 1gut-brain axisobesitytastetaste receptors

Identifiers

PMID41659336
PMCPMC12875943

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.